Skip to main content
. 2021 Jun 5;21:180. doi: 10.1186/s12911-021-01528-4

Table 2.

Basic structural elements in the identified DAs

Main topic Basic structural elements References (DA)
Target group Women with BRCA1/2 mutation [57, 58]
Women at high risk of breast cancer [59, 61, 64]
Women at high risk of ovarian cancer [60, 62, 63]
Addressed target decision Preventive options related to breast and ovarian cancer [58]
Preventive options only/mainly related to breast cancer [57, 59, 61, 64]
Preventive options only/mainly related to ovarian cancer [60, 62, 63]
Medical information Family history of breast and/or ovarian cancer (explanations, even if brief) [5964]
Impact of a pathogenic BRCA1/2 mutation (reason for high risk of breast and/or ovarian cancer) [5764]
Average morbidity rates for breast and/or ovarian cancer (text and/or number values and/or graphics) [57, 58, 6164]
(a) Lifetime risks (a) [57, 58, 6163]
(b) Time and/or age-related morbidity rates (b) [6264] (example information)
Preventive options (explanations, even if brief) [5764]
Outcomes with and without preventive measure (text and/or number values and/or graphics) [57, 58, 6064]
Consequences of the different preventive measures (text and/or number values and/or graphics) [5764]
Hormone replacement therapy to counteract consequences of risk-reducing removal of both ovaries and Fallopian tubes [60, 62, 63]
Benefits and risks of the different preventive measures and/or comparison of the options (option grid) [57, 5964]
Personal stories (testimonies) [61, 64]
Appendix with fact boxes [57, 61]
Tools for decision-making support General information on dealing with decision-making [57, 64]
Step-by-step guide to decision-making [57, 62, 63]

Tools to assist with clarifying own values and preferences, e.g

To reflect on personal opinions regarding the advantages and disadvantages of the options by answering set response options (box-ticking) and/or using note spaces for free-form reflections

To reflect on the current tendency towards or against a certain option

[57, 6163]
Question lists addressing medical information and/or doctor-patient dialogue [60, 64]
Other Glossary [57, 58]
Contact addresses and/or internet links [58, 6264]
References, further literature [5764]

BRCA1/2 BReast CAncer gene 1 and 2, DA decision aid; [5961]: a current version dated 2019 is available